Results 161 to 170 of about 4,318,091 (252)

Socioeconomic Inequalities in Receipt of Curative‐Intent Treatment and Survival After Surveillance‐Detected Hepatocellular Carcinoma: A Nationwide Cohort Study

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 5, Page 647-658, September 2026.
Socioeconomic inequalities in receipt of curative‐intent treatment and survival persist among individuals with surveillance‐detected HCC within a universal healthcare system. These findings suggest that surveillance alone is insufficient to ensure equitable outcomes and highlight the need for strategies addressing social determinants across the care ...
Hannes Hagström, Jeffrey V. Lazarus, Malin Sternby Eilard, Adam Bergman, Magnus Rizell, Per Sandström, Juan Vaz   +6 more
wiley   +1 more source

Utilizing the novel peroral choledochoscope for the treatment of hepatolithiasis about primary sclerosing cholangitis. [PDF]

Endoscopy
Qiu X, Lin X, Li Y, Zhong Z, Wang J, Peng H, Dai Z.   +6 more
europepmc   +1 more source

Cholangiocarcinoma in primary sclerosing cholangitis

, 2001
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown causes closely associated with ulcerative colitis. PSC is a progressive disease leading to liver failure and need for liver transplantation.
Annika Bergquist (243251)
core  

Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 6, Page 729-747, September 2026.
The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins, Srinivas Kamath, Rachel H. Davis, Samuel P. Costello, Robert V. Bryant, Alice S. Day, Paul Joyce   +6 more
wiley   +1 more source

Longitudinal GGT trajectories identify prognostic phenotypes in paediatric primary sclerosing cholangitis. [PDF]

JHEP Rep
Denier D, Peng YE, Amin M, Aumar M, Auth M, Tavares Fagundes ED, El-Matary W, Ferreira AR, Furuya KN, Gupta N, Guthery S, Horslen S, Jensen MK, Kamath BM, Koot BGP, Loomes KM, Mack C, Martinez M, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Stevens JP, Tessier ME, Valentino P, Deneau M, Liu K, Ricciuto A.   +27 more
europepmc   +1 more source

Primary sclerosing cholangitis [PDF]

Abdominal Imaging, 1997
Majoie, C.B.L.M., Huibregtse, K., Reeders, J.W.A.J.   +2 more
openaire   +3 more sources

Case study — primary sclerosing cholangitis

, 2012
Mortimore, Gerri
core   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction‐Associated Steatotic Liver Disease

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8277-8287, September 2026.
ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier, Ramon A. Hofmann, Michael Roden, Wolfgang Rathmann, Oliver Kuss   +4 more
wiley   +1 more source

Primary Sclerosing Cholangitis in an Elderly Female With Concomitant Gallstone Disease: A Diagnostic Challenge and Literature Review. [PDF]

Cureus
Esquivel Camacho VH, Diaz Martinez J, Albavera Rojas ÁM, Soriano Avelar VM, Palacios AE.   +4 more
europepmc   +1 more source

Senescent Human Liver Endothelial Cells Mediate CD4+ T Cell Recruitment via ICOSL

Immunology, Volume 179, Issue 1, Page 149-160, September 2026.
In this study, we detect senescent endothelial cells within chronically diseased human liver tissues. Next, we develop a novel protocol for the induction of paracrine senescence in primary human liver endothelial cells and explore their functionality.
Daniel A. Patten, Amy Lumley, Alex L. Wilkinson, Ayla O’Keeffe, Kelvin Yin, Niranjan Shirgaonkar, Ran Gao, Ramanuj DasGupta, Matthew Hoare, Shishir Shetty   +9 more
wiley   +1 more source